I’m The Only One With Genius DNA 67

I’m The Only One With Genius DNA chapter 67

The Conqueror of AIDS (1) >

Ardab was being treated at Apollo Hospital in Chennai, the largest hospital in India.

And Apollo Hospital is preparing for a major announcement today.

Reporters who were contacted had gathered countless times in the hospital lobby since morning. Among them, foreign journalists were also significant.

They had a rough idea of what today’s announcement was like.

“We have confirmed that stem cell aggregation has completely disappeared from the patient’s eyes.”

Hospital director Vikas said.

Everyone had predicted this ending when the aggregation had already been reduced to less than half the size.

But actually confirming that is another matter.

This was the same as the declaration of the end of the war between Avio and the Schmatics. The defeat of the Schmatics was already expected, but the official ruling is now over.

Avio’s glaucoma treatment kit is safe. Verification of total apoptosis of stem cells.]

[There is no tumor, and all the cells that are introduced are naturally removed.]

[Automatic destruction of all large amounts of stem cells processed up to kit 1 in the eye]

Avio’s glaucoma treatment kit does not make tumors.]

As articles were being written in real time, Vikas delivered an update.

“Additionally, we received a call from Avio a week ago.”

He said so.

“A bio promised us that Ardab’s glaucoma would be treated free of charge as soon as it was confirmed that the safeguards in the patient’s eyes had shut down and all the stem cells had died.”

This is the first time it has been disclosed.

The reporters’ eyes grew bigger.

Run, run!

Their typing hands got faster.

“Abio said he would be responsible for all the costs of sending us techniques to reverse and optic differentiation of stem cells, or transferring patient Ardab to Korea, treating and returning him to India.”

Click! Click!

Journalists took pictures of her.

Vikas said.

“We have accepted Avio’s proposal and are in talks with the patient’s part-timer. Ardab is planning to fly to Korea next week and will be treated at Avio. That’s all.”

Articles and news began to pour out. Ryu Young-joon’s choice had a significant impact.

In the midst of controversy over optic nerve therapy and automatic death of stem cells, Avio has never turned to patients.

Ryu Young-joon read an editorial in the newspaper while having breakfast.

This time, before proceeding, the press release was distributed to reporters and did not make a fuss, but this is what happened.

[Abio, Patient Ardab Appointment]

[Ryu Young-joon, CEO of Avio, is responsible for any patient treated with glaucoma kit]

The company’s image-boosting effect was more intense because it was not released by the company first.

Why didn’t Avio announce he’d be in charge of the patient? It’s simple. It’s just natural.

Professor Shin Jung-joo said.

– When I was conducting Alzheimer’s clinical trials, I had a lot of interviews with Dr. Ryu Young-joon. At that time, Dr. Ryu had only two interests.

What was it?

– How the clinical test is going and whether there are any questions for the developer himself.

Are you going to ask me a question?

Yes, Dr. Liu is a very classic scientist. He is a person who tries to be responsible for all of his data and technology. If something unexpected happens, you think you should come up with an answer, no matter how little it is.

I see.

Actually, that’s the right thing to do. That’s the attitude of a real technology developer and scientist. Dr. Liu thinks it’s natural that the patient in India is also trying to proceed with the treatment.

You said that’s a given, are there many people who don’t these days?

– There are a lot. I think pharmaceutical scientists have lost their craftsmanship these days. When I get a report that says “it doesn’t work” about my development, I don’t answer anything about it.

Are you just ignoring him?

Yes, especially big pharmaceutical companies, they just destroy data that says no. As a doctor, if I report any side effects of using the drugs they have developed, no answers are returned, and the side effects report itself often does not go into the pharmacological data they present. It’s a deliberate disregard.

Professor Shin Jung-joo said as if he was annoyed.

– Not even post-productification data feedback, but they often do so from the clinical trial stage. It just removes reports of patients with no medicinal effects or side effects. Among the products of large pharmaceutical companies, there are some clinical trial data that are not fully disclosed, which has destroyed the data that are unfavorable to the utility of the product.

– Not even post-productification data feedback, but they often do so from the clinical trial stage. It just removes reports of patients with no medicinal effects or side effects. Among the products of large pharmaceutical companies, there are some clinical trial data that are not fully disclosed, which has destroyed the data that are unfavorable to the utility of the product.

Oh… Do you have a lot of drugs like that?

– The famous flu treatments we all know are one such case. Doctors once complained to release all the data.

Oh, that’s shocking.

Yes, of course, pharmaceutical companies shouldn’t act like that. If there is feedback that there is a problem, or if there is a failure to treat it with the product, the manufacturer needs to diagnose the problem and take responsibility until the end.

Professor Shin Jung-joo said.

Take a look at Avio now. Even though this was manipulated by Schumatics from the beginning, isn’t it because he’s a patient who failed to treat it with Avio’s product anyway? It’s a mess from Schumatics, but he’s going to clean it up.

The more I look at it, the more I can’t help but admire it.

– This is the attitude of an expert.

Shin Jung-ju said.

The public doesn’t know much about science or medicine, do they? I’m sick and my life is going back and forth, but Avio did well and Schumatics didn’t do well. I’m not really interested in that. That’s what you’re going to do, and you’re going to take care of me. That’s how most patients feel.

They’re the only people patients can count on.

That’s right, what if those smart professionals are distracted by their own fighting and neglecting their patients unattended? That’s why Avio focuses on the patient.

You mean, even if Schumatics did something wrong, it was Avio’s product, and you’re responsible for the treatment of patients as the world’s best glaucoma specialist within the huge boundaries of medicine?

-That’s exactly what it is it. That’s exactly what a “professional” looks like. I hope other scientists and medical professionals will emulate the attitude Avio is showing now.

***

Fighting Schumatics, treating Ardab, is a separate story from research. Research should continue even if they are busy. To not make progress is not to stagnate, but to regress.

In many ways, Ryu Young-joon continued to make progress in his research.

Thanks to this, Samuel, the Science editor, was able to receive another paper.

“Crisper-Casnine accurate correction of target DNA…”…”

He frowned as he read the title of the paper.

“What are you talking about?”

Some overwhelming techniques are sometimes intuitively incomprehensible at once.

Samuel slowly re-read the summary of the paper with a bewildering look on his face.

“Argh!”

At the same time, Jessie, who understood the point of the paper a little earlier than that, screamed.

“What the……”

She was speechless for a moment in shock and ran straight to Samuel straight away.

“Samuel, did you read Dr. Liu’s thesis?”

“I’m looking at the summary right now and what does this mean?”

Samuel said.

“If it wasn’t for Dr. Ryu’s paper, I would have thrown it away. There’s no animal experiment data in the paper, and most of them are in vitro data, and one cell experiment is the only.”

He shook the papers.

“I can’t believe I’m sending a paper to Science that I’ve written in such poor data. It’s not like Dr. Ryu doesn’t know what science is like. I’m so confident that every paper he sends me has been published.…”

“Samuel! Reporting in this paper is a new paradigm for gene correction!”

shouted Jessie.

“The story of gene correction is in the summary, but I haven’t finished reading the text yet.…”

“Take your time and read it carefully. It’s a genetic scissors that can cut all three billion base pairs of human DNA. You can cut anywhere you want!”

“Every position means every gene?”

“No, that’s great, but this technology is all about DNA.”

DNA is a much larger concept than genes. Genes that produce biomaterials throughout DNA are only about 2 percent.

Others do miscellaneous things such as controlling the expression of genes or maintaining the structure of DNA.

You can manipulate the entire DNA.

In terms of the number of characters, it’s 3 billion.

A miracle new technology that allows us to freely locate and edit any location in that vast, human natural database at most library level.

Samuel’s mouth slowly opened as he read the text of the paper.

This is more than a reverse differentiated stem cell technology.

Theoretically, it can cure all the “problems” in human DNA.

All kinds of genetic diseases, and all kinds of cancer.

It is a technology that has the potential to cure all diseases that start with DNA errors.

“Oh, my God…”

“Oh, my God…”

Samuel’s hands trembled.

“Look closely at the one cell experiment data.”

Jessie said. Samuel quickly handed over the paper and found the cell experiment data.

“Editing CCR5, the gene of hematopoietic stem cells that have been differentiated into reverse differentiated stem cells.…”

Samuel read the paper.

“You cut the CCR5 and destroyed it?”

Samuel tilted his head.

“Don’t you remember what gene that is?”

“I’ve heard of it somewhere.”

“It was reported during Timothy Ray Brown. A channel of HIV infection.”

I got goosebumps all over Samuel’s spine.

“It’s not the AIDS cure technology?

He swallowed his saliva.

***

After sending the paper, Ryu Young-joon presented his AIDS treatment technology at a meeting with the bone marrow regeneration team.

“……that’s why we can operate the CCR5 in this way. After entering the RNA that matches the sequence of the CCR5 gene in the casnine, the casnine finds the CCR5 gene and cuts it off. After the cell is modified, the structure changes and no longer works.”

Ryu Young-joon said.

“With the stem cells that Dr. Lee Jung-hyuk received, we processed them in this way to create stem cells that manipulated CCR5, and we cultivated them to create hematopoietic stem cells. I checked that CCR5 is not made with Western Blot. I think transplanting this into the patient’s bone marrow will cure AIDS. It’s the same case of treatment you put in patient Timothy Ray Brown’s bone marrow.”

“…….”

There was a shocking silence in the meeting room.

Carpentier quietly put down his Americano.

“Dr. Ryu, that technique is more than just treating genetic diseases and AIDS. You know what I’m talking about, right?

“Yes.”

“That’s a technology that’s capable of ‘genetic manipulated.

“That’s right.”

“In a decade or so, there may be people trying to genetically manipulate their babies with that technology.”

Ryu Young-joon nodded.

“I know.”

Transplanting bone marrow with a broken gene called CCR5 can cure AIDS.

In other words, manipulating CCR5 from the fertilized egg stage could give birth to a baby that is immune to AIDS.

When Cassnine is announced, research will certainly begin in that direction.

It’s no use anyone stopping it. Technological development goes beyond ethics when given enough time.

It’ll start with an HIV-immune baby, but what if it goes further?

You can also create a customized baby by manipulating genes that determine height, vision, and skin.

Everyone won’t be able to be scared at first, but eventually there will be people trying to do it one by one.

There will be enormous ethical issues.

Will mankind be able to afford that future?

If something goes wrong, perhaps Ryu Young-joon, who first found the technology, will receive a huge arrow of criticism.

“So I had a lot of trouble revealing this technology.”

Ryu Young-joon said.

“But you finally decided to write it?”

“Yes.”

Ryu Young-joon replied firmly.

“Because I can’t leave people suffering from AIDS alone.”

“……. It’s certainly a shocking technology beyond shocking.”

Carpentier said.

“I agree with Dr. Ryu for now. And I’m in favor of treating AIDS by manipulating CCR5 with that technology.”

“Thank you.”

“But I’m sure religious or conservative groups will pick a fight about this technology. Maybe it’s harder to deal with than the Schumatics.”

Carpentier warned.

Carpentier warned.

“I know.”

Ryu Young-joon replied.

“But everyone. There are more than 30 million AIDS patients in the world. And there will be hundreds of millions of people with genetic diseases that this technology can cure in the future.”

Ryu Young-joon said.

“I’m afraid of the uncertain dangers of the future that have not come, and I’m not going to let people struggling in pain right now. If there’s a problem with this technology, solving it will be science.”

“I’m afraid of the uncertain dangers of the future that have not come, and I’m not going to let people struggling in pain right now. If there’s a problem with this technology, solving it will be science.”

I’m The Only One With Genius DNA chapter 67

|

ToC

|